Albumin-interferon alpha API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Albumin-interferon alpha API 472960-22-8?
- Description:
- Here you will find a list of producers, manufacturers and traders of Albumin-interferon alpha. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Albumin-interferon alpha
- Synonyms:
- Albinterferon , Albinterferon alfa-2b
- Cas Number:
- 472960-22-8
- DrugBank number:
- DB05396
- Unique Ingredient Identifier:
- 4DVS4AG4DF
About Albumin-interferon alpha
What makes Albinterferon Alfa-2B unique? Albumin-interferon alpha (Albuferon) is a novel, long-acting form of interferon alpha. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B, and a broad range of cancers. Human Genome Sciences modified interferon alpha to improve its pharmacological properties by using the company's proprietary albumin fusion technology. Human Genome Sciences is developing Albuferon as a potential treatment for chronic hepatitis C.
The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C. In response to an FDA ruling, Novartis and Human Genome Sciences announced on October 5, 2010 that they ceased development of the drug.
Ask the supplier for a certificate of analysis to find out more about the quality of Albinterferon Alfa-2B.
